This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karpe, F. Articles by Hodson, L. Search for Related Content PubMed Articles by Karpe, F. Articles by Hodson, L.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e152.)
© 2008 American Heart Association, Inc.

Letters to the Editor

Caution on the Interpretation of Plasma Fatty Acid Composition as a Proxy Marker for SCD1 Activity: Particular Implications for Using the 16:1/16:0 Ratio in QTL Studies Involving Hyperlipidemic Patients

Fredrik Karpe; Leanne Hodson

Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, UK

An extract of the first 250 words of the full text is provided, because this article has no abstract.

To the Editor:

Recently, Aldons Lusis and coworkers suggested a relationship between stearoyl-coenzyme A (CoA) desaturase-1 (SCD1) activity and familial combined hyperlipidemia (FCH).¹ The relationship between SCD1 and metabolic features related to FCH has attracted interest because it was shown that the SCD1 knockout mouse is obesity-resistant on high-fat feeding and has increased insulin sensitivity.²

The surrogate marker used for SCD1 activity is often the ratio of the product and precursor for the SCD1 enzymatic step, ie, either the ratio between 16:1n-7 and 16:0 or that of 18:1n-9 and 18:0 in plasma samples. Not only is this ratio very much dependent on previous food intake, it is also influenced by the fraction of lipids in plasma in which it is analyzed.³ The main plasma lipid fractions containing fatty acids are triglycerides, phospholipids, cholesteryl esters, and nonesterified fatty acids. Phospholipids, which have typical plasma concentrations of 2 to 3 mmol/L, show clear signs of fatty acid partitioning. They are enriched in long-chain polyunsaturated fatty acids, mainly 18:2n-6, but are relatively poor in, for example, 16:1n-7.³ Compared with plasma triglycerides, the plasma phospholipids are also poor in 18:1n-9 and rich in 18:0.³ Typical molar % of 16:1n-7 and 16:0 in plasma phospholipids are 2 and 30, whereas the average values for plasma triglycerides are 5% and 30%.³ The corresponding values for 18:1n-9 and 18:0 in plasma triglycerides are 28% and 4.5%, respectively, whereas the relative values are 10% and 14% for phospholipids. Importantly, the abundance of plasma phospholipids does not increase in . . . [Full Text of this Article]

This article has been cited by other articles:

				A. Peter, A. Cegan, S. Wagner, R. Lehmann, N. Stefan, A. Konigsrainer, I. Konigsrainer, H.-U. Haring, and E. Schleicher Hepatic Lipid Composition and Stearoyl-Coenzyme A Desaturase 1 mRNA Expression Can Be Estimated from Plasma VLDL Fatty Acid Ratios Clin. Chem., December 1, 2009; 55(12): 2113 - 2120. [Abstract] [Full Text] [PDF]

				M. T. Flowers The {Delta}9 Fatty Acid Desaturation Index as a Predictor of Metabolic Disease Clin. Chem., December 1, 2009; 55(12): 2071 - 2073. [Full Text] [PDF]